MiR-107 function as a tumor suppressor gene in colorectal cancer by targeting transferrin receptor 1
- PMID: 31131011
- PMCID: PMC6524234
- DOI: 10.1186/s11658-019-0155-z
MiR-107 function as a tumor suppressor gene in colorectal cancer by targeting transferrin receptor 1
Abstract
Background: While microRNAs (miRNAs) are known to play a critical role in the progression of colorectal cancer, the role of miR-107 remains unknown. We evaluated its role and explored the underlying mechanism.
Materials & methods: MTT, wound-healing, transwell migration and transwell invasion assays were performed to evaluate the role of miR-107 in SW629 cell proliferation, migration and invasion. Real time-PCR and dual-luciferase reporter gene, TFR1 overexpression and western blotting assays were used to explore the underlying mechanism.
Results: MiR-107 is downregulated in colorectal cancer tissues and several human colorectal cancer cell lines. Low miR-107 expression often indicates a poor survival rate for colorectal cancer patients. MiR-107 suppresses the proliferation, migration and invasion of SW620 cells by negatively regulating transferrin receptor 1 (TFR1).
Conclusion: MiR-107 suppresses the metastasis of colorectal cancer and could be a potential therapy target in colorectal cancer patients.
Keywords: Cancer progress; Colorectal cancer; Transferrin receptor 1 (TFR1); microRNA107 (miR-107).
Conflict of interest statement
Competing interestsThe authors declare that they have no competing interests.
Figures
Similar articles
-
MiR-141-3p inhibits cell proliferation, migration and invasion by targeting TRAF5 in colorectal cancer.Biochem Biophys Res Commun. 2019 Jun 30;514(3):699-705. doi: 10.1016/j.bbrc.2019.05.002. Epub 2019 May 9. Biochem Biophys Res Commun. 2019. PMID: 31078266
-
NLK, a novel target of miR-199a-3p, functions as a tumor suppressor in colorectal cancer.Biomed Pharmacother. 2014 Jun;68(5):497-505. doi: 10.1016/j.biopha.2014.05.003. Epub 2014 Jun 9. Biomed Pharmacother. 2014. PMID: 24972723
-
miR-539 inhibits human colorectal cancer progression by targeting RUNX2.Biomed Pharmacother. 2017 Nov;95:1314-1320. doi: 10.1016/j.biopha.2017.09.044. Epub 2017 Oct 6. Biomed Pharmacother. 2017. PMID: 28938522 Retracted.
-
Transcription factor SP1-induced microRNA-146b-3p facilitates the progression and metastasis of colorectal cancer via regulating FAM107A.Life Sci. 2021 Jul 15;277:119398. doi: 10.1016/j.lfs.2021.119398. Epub 2021 Apr 5. Life Sci. 2021. PMID: 33831429
-
Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells.Cancer Genet. 2019 Feb;231-232:22-31. doi: 10.1016/j.cancergen.2018.12.004. Epub 2018 Dec 27. Cancer Genet. 2019. PMID: 30803553
Cited by
-
LINC00662 promotes melanoma progression by competitively binding miR-107 and activating the β-catenin signaling pathway.Int J Med Sci. 2024 Jan 1;21(2):265-276. doi: 10.7150/ijms.84072. eCollection 2024. Int J Med Sci. 2024. PMID: 38169586 Free PMC article.
-
Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer.Transl Oncol. 2024 Feb;40:101846. doi: 10.1016/j.tranon.2023.101846. Epub 2023 Dec 1. Transl Oncol. 2024. PMID: 38042134 Free PMC article. Review.
-
Emerging roles of ferroptosis-related miRNAs in tumor metastasis.Cell Death Discov. 2023 Jun 27;9(1):193. doi: 10.1038/s41420-023-01486-y. Cell Death Discov. 2023. PMID: 37369681 Free PMC article. Review.
-
HIF-1-Induced hsa-miR-429: Understanding Its Direct Targets as the Key to Developing Cancer Diagnostics and Therapies.Cancers (Basel). 2023 May 25;15(11):2903. doi: 10.3390/cancers15112903. Cancers (Basel). 2023. PMID: 37296866 Free PMC article. Review.
-
Iron metabolism in colorectal cancer: a balancing act.Cell Oncol (Dordr). 2023 Dec;46(6):1545-1558. doi: 10.1007/s13402-023-00828-3. Epub 2023 Jun 5. Cell Oncol (Dordr). 2023. PMID: 37273145 Free PMC article. Review.
References
-
- Bahreyni A, Rezaei M, Bahrami A, Khazaei M, Fiuji H, Ryzhikov M, Ferns GA, Avan A, Hassanian SM. Diagnostic, prognostic, and therapeutic potency of microRNA 21 in the pathogenesis of colon cancer, current status and prospective. J Cell Physiol. 2019;234(6):8075–8081. doi: 10.1002/jcp.27580. - DOI - PubMed
-
- Ota M, Takamura N, Irimura T. Involvement of cell surface glycans in adhesion of human colon carcinoma cells to liver tissue in a frozen section assay: role of endo-beta-galactosidase-sensitive structures. Cancer Res. 2000;60:5261–5268. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
